Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

NCT00396227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2665

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin
DRUG: thiazolidinedione (TZD)

Sponsor

Novartis Pharmaceuticals